STAT3 in cancer: A double edged sword-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STAT3 in cancer: A double edged sword

Published:2017-10 Issue: Volume:98 Page:42-50
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Avalle Lidia,Camporeale Annalisa,Camperi Andrea,Poli Valeria

Funder

Cancer Research Association

San Paolo Foundation

Italian Ministry for the University and Research

Truus and Gerrit van Riemsdijk Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference152 articles.

1. STAT proteins: novel molecular targets for cancer drug discovery;Turkson;Oncogene,2000

2. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity;Siddiquee;Proc. Natl. Acad. Sci. U.S.A,2007

3. JAK-STAT signaling: from interferons to cytokines;Schindler;J. Biol. Chem.,2007

4. Revisiting STAT3 signalling in cancer: new and unexpected biological functions;Yu;Nat. Rev. Cancer,2014

5. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer;Yuan;Sci. Rep.,2015

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents;In Silico Pharmacology;2024-09-14

2. Neurotoxic effects of triclosan in adolescent mice: Pyruvate kinase M2 dimer regulated Signal transducer and activator of transcription 3 phosphorylation mediated microglia activation and neuroinflammation;Science of The Total Environment;2024-09

3. Feasibility of the inhibitor development for cancer: A systematic approach for drug design;PLOS ONE;2024-08-22

4. Age‐associated myeloid malignancies – the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia;FEBS Letters;2024-07-24

5. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis;Critical Reviews in Oncology/Hematology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3